株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の感染症診断市場の分析

Analysis of the Global Infectious Disease Diagnostics Market

発行 Frost & Sullivan 商品コード 314821
出版日 ページ情報 英文 134 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.77円で換算しております。
Back to Top
世界の感染症診断市場の分析 Analysis of the Global Infectious Disease Diagnostics Market
出版日: 2014年09月23日 ページ情報: 英文 134 Pages
概要

当レポートでは、全世界の感染症診断市場について分析し、市場全体および分野別(免疫診断、分子診断、臨床微生物学的診断など)の市場収益額の見通しや、主な市場促進・抑制要因、技術開発の動き、主要企業の競争力と市場戦略、注目すべき企業、各地域市場の詳細行動・動向などを調査・推計しております。

当レポートは、以下の疑問にお答えいたします。

  • 世界各国の市場参入企業にとって、市場構造を変革させられるような戦略とは何か?
  • 市場の主な促進要因・抑制要因は何か?
  • 市場の主導的な企業はどれか?各社はどうやって課題を解決しているのか?
  • 目下のアンメットニーズは何か?各企業はそれらの解決にむけてどう対処しているのか?
  • 米国・西欧市場において、どの疾患が市場収益額の点で最も貢献しているのか?
  • 最も急速に成長している市場分野はどれか?市場成長は今後5年間にわたり継続するのか?

第1章 エグゼクティブ・サマリー

第2章 市場概況

  • 市場の背景事情:感染症の場合
  • 市場の背景事情:敗血症
  • 市場の背景事情:結核
  • 市場の背景事情:メチシリン耐性黄色ブドウ球菌(MRSA)
  • 市場の背景事情:B型・C型肝炎
  • 市場の背景事情:ハンタウイルス
  • 市場の分類:定義
  • 市場の分類
  • 医療市場の動向

第3章 競合戦略

  • 各疾患の治療法
  • 新たな市場機会
  • 企業合併・買収(M&A)および事業提携の評価

第4章 市場の促進・抑制要因と傾向

  • 市場促進要因
  • 市場抑制要因

第5章 市場の予測と傾向

  • 市場計測
  • 市場予測の前提条件と定義
  • 市場収益額の予測
  • 収益額シェアの予測:地域別
  • 収益額の予測:地域別
  • 収益額シェアの予測:分野別
  • 収益額の予測:分野別
  • 各分野のライフサイクルの分析

第6章 競争環境

  • 競争環境
  • 上市済み製品の分析:結核
  • 上市済み製品の分析:敗血症
  • 上市済み製品の分析:MRSA
  • 上市済み製品の分析:B型・C型肝炎
  • 主要企業

第7章 米国市場の分析

  • 市場計測
  • 市場収益額の予測
  • 市場収益額の予測:疾患別
  • 市場収益額の予測:分野別
  • 米国市場の分析
  • PESTLE分析
  • 主要動向の市場への影響
  • 階層別の市場シェア
  • 階層別の分析

第8章 西欧市場の分析

第9章 アジア太平洋地域(APAC)および他の国々(ROW)の市場の分析

第10章 注目すべき企業

  • Reagena
  • Nanomix
  • Anagnostics GmbH

第11章 結論

  • 分析結果:3つの主な予測
  • 法的免責事項

第12章 付録

図表一覧

目次
Product Code: NE02-01-00-00-00

Molecular Methods Present Significant Opportunities

This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalence of these diseases and the growing demand for rapid diagnostic tests. Regional breakdowns are provided for three market segments: immunodiagnostics, molecular methods, and clinical microbiology. Regional breakdowns by disease also are provided. The base year for the study is 2013; the forecast period is from 2014 to 2018.

Key Questions This Study Will Answer

  • What are some of the game-changing strategies for global market participants?
  • What are the key market drivers and restraints?
  • Who are the market leaders, and how are they overcoming industry challenges?
  • What are the unmet market needs, and how are market participants working to meet these needs?
  • Which diseases contribute significantly to market revenue in the United States and Western Europe?
  • What are the fastest-growing market segments? Is growth sustainable over the next 5 years?

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Scope and Segmentation
  • 4. Top Diseases by Region
  • 5. Diseases and Available Solutions in the Global Market
  • 6. Key Questions This Study Will Answer
  • 7. Measurements
  • 8. CEO's Perspective
  • 9. Key Companies to Watch
  • 10. Executive Summary-3 Big Predictions

2. MARKET OVERVIEW

Market Overview

  • 1. Market Background-Infectious Diseases
  • 2. Disease Background-Sepsis
  • 3. Disease Background-TB
  • 4. Disease Background-MRSA
  • 5. Disease Background-Hepatitis B and C
  • 6. Disease Background-Hepatitis B and C (continued)
  • 7. Disease Background-Hantavirus
  • 8. Market Segmentation-Definitions
  • 9. Market Segmentation
  • 10. Healthcare Trends

3. COMPETITIVE PLAYBOOK

Competitive Playbook

  • 1. Solutions Provided for Each Disease
  • 2. New Market Opportunities
  • 3. New Market Opportunities (continued)
  • 4. New Market Opportunities (continued)
  • 5. Merger, Acquisition, and Partnership Assessment
  • 6. Merger, Acquisition, and Partnership Assessment (continued)
  • 7. Merger, Acquisition, and Partnership Assessment (continued)

4. DRIVERS, RESTRAINTS, AND TRENDS-TOTAL INFECTIOUS DISEASE DIAGNOSTICS MARKET

Drivers, Restraints, and Trends-Total Infectious Disease Diagnostics Market

  • 1. Market Drivers
  • 2. Market Restraints

5. FORECAST AND TRENDS-TOTAL INFECTIOUS DISEASE DIAGNOSTICS MARKET

Forecast and Trends-Total Infectious Disease Diagnostics Market

  • 1. Measurements
  • 2. Forecast Assumptions and Definitions
  • 3. Revenue Forecast
  • 4. Revenue Forecast Discussion
  • 5. Percent Revenue Forecast by Region
  • 6. Revenue Forecast by Region
  • 7. Percent Revenue Forecast by Segment
  • 8. Revenue Forecast by Segment
  • 9. Revenue Forecast by Segment Discussion
  • 10. Revenue Forecast by Segment Discussion (continued)
  • 11. Revenue Forecast by Segment Discussion (continued)
  • 12. Segment Lifecycle Analysis

6. COMPETITIVE ENVIRONMENT

Competitive Environment

  • 1. Competitive Environment
  • 2. Marketed Product Analysis-TB
  • 3. Marketed Product Analysis-TB (continued)
  • 4. Marketed Product Analysis-Sepsis
  • 5. Marketed Product Analysis-MRSA
  • 6. Marketed Product Analysis-Hepatitis B/C
  • 7. Marketed Product Analysis-Hepatitis B/C (continued)
  • 8. Top Competitors
  • 9. Top Competitors (continued)
  • 10. Top Competitors (continued)

7. US MARKET ANALYSIS

US Market Analysis

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast by Disease
  • 4. Revenue Forecast Discussion
  • 5. Revenue Forecast by Segment
  • 6. Revenue Forecast by Segment Discussion
  • 7. Revenue Forecast by Segment Discussion (continued)
  • 8. Revenue Forecast by Segment Discussion (continued)
  • 9. US-Market Analysis
  • 10. PESTLE Analysis
  • 11. Market Impact of Top Trends
  • 12. US-Market Share by Tier
  • 13. US-Tier Analysis
  • 14. US-Tier Analysis (continued)
  • 15. US-Tier Analysis (continued)

8. WESTERN EUROPE MARKET ANALYSIS

Western Europe Market Analysis

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast by Disease
  • 4. Revenue Forecast Discussion
  • 5. Revenue Forecast by Segment
  • 6. Revenue Forecast by Segment Discussion
  • 7. Revenue Forecast by Segment Discussion (continued)
  • 8. Revenue Forecast by Segment Discussion (continued)
  • 9. PESTLE Analysis
  • 10. Market Impact of Top Trends
  • 11. Western Europe-Market Analysis
  • 12. Western Europe-Market Share by Tier
  • 13. Western Europe-Tier Analysis
  • 14. Western Europe-Tier Analysis (continued)
  • 15. Western Europe-Tier Analysis (continued)

9. APAC & ROW MARKET ANALYSIS

APAC & ROW Market Analysis

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast Discussion
  • 4. Revenue Forecast by Segment
  • 5. Revenue Forecast by Segment Discussion
  • 6. Revenue Forecast by Segment Discussion (continued)
  • 7. Revenue Forecast by Segment Discussion (continued)
  • 8. PESTLE Analysis
  • 9. Market Impact of Top Trends
  • 10. APAC & ROW-Market Analysis
  • 11. APAC & ROW-Market Share by Tier
  • 12. APAC & ROW-Tier Analysis
  • 13. APAC & ROW-Tier Analysis

10. KEY COMPANIES TO WATCH

Key Companies to Watch

  • 1. Reagena
  • 2. Nanomix
  • 3. Anagnostics GmbH

11. THE LAST WORD

The Last Word

  • 1. The Last Word-3 Big Predictions
  • 2. The Last Word-Discussion
  • 3. The Last Word-Discussion (continued)
  • 4. The Last Word-Discussion (continued)
  • 5. Legal Disclaimer

12. APPENDIX

Appendix

  • 1. Drivers Explained
  • 2. Drivers Explained (continued)
  • 3. Restraints Explained
  • 4. Restraints Explained (continued)
  • 5. Restraints Explained (continued)
  • 6. List of Other Companies-United States
  • 7. List of Other Companies-Western Europe
  • 8. List of Other Companies-APAC and ROW
  • 9. Associated Multimedia
  • 10. Associated Multimedia (continued)
  • 11. Methodology
  • 12. List of Exhibits
  • 13. List of Exhibits (continued)
  • 14. List of Exhibits (continued)
  • 15. List of Exhibits (continued)

List of Exhibits

  • Total Infectious Disease Diagnostics Market: Diseases Covered by Each Region, Global, 2013
  • Total Infectious Disease Diagnostics Market: Diagnostic Testing Availability by Segment, Global, 2013
  • Total Infectious Disease Diagnostics Market: Market Engineering Measurements, Global, 2013
  • Total Infectious Disease Diagnostics Market: Key Definitions, Global, 2013
  • Total Infectious Disease Diagnostics Market: Market Segmentation, Global, 2013
  • Total Infectious Disease Diagnostics Market: Market Outlook, Global, 2013 and 2023
  • Total Infectious Disease Diagnostics Market: Company Offerings, Global, 2013
  • Total Infectious Disease Diagnostics Market: Game-changing Strategies, Global, 2013
  • Total Infectious Disease Diagnostics Market: Acquisitions and Partnerships, Global, 2013
  • Total Infectious Disease Diagnostics Market: Key Market Drivers, Global, 2014-2018
  • Total Infectious Disease Diagnostics Market: Key Market Restraints, Global, 2014-2018
  • Total Infectious Disease Diagnostics Market: Market Engineering Measurements, Global, 2013
  • Total Infectious Disease Diagnostics Market: Revenue Forecast, Global, 2011-2018
  • Total Infectious Disease Diagnostics Market: Percent Revenue Forecast by Region, Global, 2011-2018
  • Total Infectious Disease Diagnostics Market: Revenue Forecast by Region, 2011-2018
  • Total Infectious Disease Diagnostics Market: Percent Revenue Forecast by Segment, Global, 2011-2018
  • Total Infectious Disease Diagnostics Market: Revenue Forecast by Segment, Global, 2011-2018
  • Total Infectious Disease Diagnostics Market: Segment Lifecycle Analysis, Global, 2013
  • Total Infectious Disease Diagnostics Market: Competitive Structure, Global, 2013
  • Total Infectious Disease Diagnostics Market: Marketed Product Analysis (TB), Global, 2013
  • Total Infectious Disease Diagnostics Market: Marketed Product Analysis Sepsis), Global, 2013
  • Total Infectious Disease Diagnostics Market: Marketed Product Analysis (MRSA), Global, 2013
  • Total Infectious Disease Diagnostics Market: Marketed Product Analysis (Hepatitis B/C), Global, 2013
  • Total Infectious Disease Diagnostics Market: SWOT Analysis, Global, 2013
  • Infectious Disease Diagnostics Market: Market Engineering Measurements, US, 2013
  • Infectious Disease Diagnostics Market: Revenue Forecast, US. 2011-2018
  • Infectious Disease Diagnostics Market: Revenue Forecast by Disease, US, 2011-2018
  • Infectious Disease Diagnostics Market: Revenue Forecast by Segment, US, 2011-2018
  • Infectious Disease Diagnostics Market: PESTLE Analysis, US, 2013
  • Infectious Disease Diagnostics Market: Impact of Top 5 Trends, US, 2013
  • Infectious Disease Diagnostics Market: Market Share Analysis, US, 2013
  • Infectious Disease Diagnostics Market: Market Engineering Measurements, Western Europe, 2013
  • Infectious Disease Diagnostics Market: Revenue Forecast, Western Europe, 2011-2018
  • Infectious Disease Diagnostics Market: Revenue Forecast by Disease, Western Europe, 2011-2018
  • Infectious Disease Diagnostics Market: Revenue Forecast by Segment, Western Europe, 2011-2018
  • Infectious Disease Diagnostics Market: PESTLE Analysis, Western Europe, 2013
  • Infectious Disease Diagnostics Market: Impact of Top 5 Trends, Western Europe, 2013
  • Infectious Disease Diagnostics Market: Market Share Analysis, Western Europe, 2013
  • Infectious Disease Diagnostics Market: Market Engineering Measurements, APAC & ROW, 2013
  • Infectious Disease Diagnostics Market: Revenue Forecast, APAC & ROW, 2011-2018
  • Infectious Disease Diagnostics Market: Revenue Forecast by Segment, APAC & ROW, 2011-2018
  • Infectious Disease Diagnostics Market: PESTLE Analysis, APAC & ROW, 2013
  • Infectious Disease Diagnostics Market: Impact of Top 5 Trends, APAC & ROW, 2013
  • Infectious Disease Diagnostics Market: Market Share Analysis, APAC & ROW, 2013
Back to Top